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Coronavirus mRNA Synthesis: Identification of Novel Transcription Initiation Signals 
Which Are Differentially Regulated by Different Leader Sequences 
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The mRNA synthesis of mouse hepatitis virus (MHV) has been proposed to be the result of interaction between the 
leader RNA and the intergenic sites. Previously, we have identified a transcription initiation site (for mRNA 2-l), which 
is more efficiently transcribed by viruses containing two copies of UCUAA sequence in the leader RNA than by those 
with three copies. In this study, we have identified several sites which are regulated in the opposite way, namely, they 
are efficiently transcribed by the leader RNA with three UCUAA copies but not by those with two copies. These sites 
were characterized by primer extension and amplification by polymerase chain reaction. One of these sites is in the 
gene 3 region of a recombinant virus between A59 and JHM strains of MHV. Another is in the gene 2 region of MHV-1 
strain. Both of these sites have a sequence similar to but different from the consensus transcription initiation signal 
(UCUAAUCUAUC and UUUAAUCUU, as opposed to UCUAAAC). These two novel intergenic sequences are not pres- 
ent in the genome of the JHM strain, consistent with the absence of these mRNAs in the JHM-infected cells. The 
discovery of this type of transcription initiation site provides additional evidence for the importance of the leader RNA in 
the transcription initiation of MHV mRNAs. o 1992 Academic PWSS. IIIC. 
Mouse hepatitis virus (MHV), a member of the Co- 
ronaviridae, is an enveloped virus containing a nonseg- 
mented positive-sensed RNA genome of 31 kb (I, 2). 
MHV synthesizes seven to eight virus-specific mRNAs 
that have a 3’-coterminal nested-set structure (1, 3). 
The 5’ unique portion of each mRNA is utilized for 
translation (4, 5). These mRNAs encode four structural 
proteins, including S (spike), translated from mRNA 3, 
N (nucleocapsid) from mRNA 7, M (membrane) from 
mRNA 6, and HE (hemagglutinin-esterase) from mRNA 
2-l. Other mRNAs encode nonstructural proteins, 
which have not been well characterized [for review, 
see Ref. (I)]. mRNA 2-1 is unusual in that it is synthe- 
sized by only some, but not all, of the MHV strains (6); 
its presence or absence is apparently regulated by a 
stretch of leader sequence located at the 5’-end of the 
genomic RNA (7). This leader RNA sequence (approxi- 
mately 72 nucleotides) is also found at the 5’-end of 
every MHV mRNA species (8). 
the leader RNA makes only a small quantity of mRNA 
2-1, while the same virus with two copies makes a 
large quantity of this transcript (7, 10). The amounts of 
some other mRNAs, e.g., mRNA 2 and 4, are also af- 
fected, but to a much smaller extent (7, 10). 
At the 3’-end of the leader sequence, there are sev- 
eral copies of a repeat pentanucleotide sequence 
UCUAA, whose copy number varies from two to four, 
depending on the virus strain (9) and decreases upon 
serial passage of the virus in vitro (70). Significantly, a 
JHM virus which contains three copies of UCUAA in 
’ Present address: lstituto di Ricerche di Biologia Molecolare, Po- 
mezia, Rome, Italy. 
The level of mRNA 2-l expression can also be af- 
fected by the sequence at the transcription initiation 
site for this mRNA. For example, the A59 strain of MHV 
has a single base substitution within this transcription 
initiation site and does not synthesize mRNA 2-1, de- 
spite the presence of two UCUAA copies (7, 11). These 
results suggest that MHV mRNA synthesis is deter- 
mined by the interaction between the leader RNA and 
the intergenic sites. Thus, the intergenic sequence for 
gene 2-1 may represent a unique class of sequence 
which is differentially regulated by leader RNAs with 
different UCUAA copy numbers. The basis for this dif- 
ferential regulation of transcription is not clear. To un- 
derstand the mechanism of MHV mRNA transcription, 
we have attempted to determine whether the differen- 
tial regulation of transcription initiation by leader RNA 
containing different UCUAA copy numbers is unique to 
mRNA 2-l. In this report, we have identified several 
additional transcription initiation sites which are regu- 
lated in different manners by leader RNA with different 
copy numbers of the UCUAA sequence. These studies 
provide further insight into the mechanism of MHV 
mRNA transcription. 
’ To whom correspondence and reprint requests should be ad- We previously obtained a recombinant virus Bl be- 
dressed. tween the A59 and JHM strains of MHV (12). This virus 
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FIG. 1. Electrophoretic analysis of virus-specific intracellular RNAs 
of various MHV strains. Viruses were grown in mouse astrocytoma 
cell line DBT (17) and labeled with 0.2 mCi/ml of [32P]- 
orthophosphate between 5 and 9 hr p.i. RNA was extracted from the 
infected cells, denatured with glyoxal and DMSO, and analyzed by 
electrophoresis on a 1% agarose gel as described (18). 
has a genome structure in which the 5’-end of the ge- 
nome, including the leader RNA and part of gene 1, 
was derived from JHM, while the remaining sequence 
was from A59 (12). This virus synthesized a novel 
mRNA 3-1 (previously named 3a), which was initiated 
within the gene 3 (12). By passaging Bl virus in tissue 
culture, a new virus isolate was obtained, which dif- 
fered from the original Bl virus in that it had two copies 
of the UCUAA sequence in the leader, in contrast to 
the three copies in the original virus (10). This virus 
isolate synthesized only a trace amount of mRNA 3-l 
(10). The analysis of several other recombinant viruses 
with different genome structures suggested that 
mRNA 3-l was synthesized only by viruses with a 
leader RNA containing three copies of UCUAA and 
gene 3 sequence derived from A59 but not JHM (10, 
13). These observations suggested a new type of op- 
tional transcription initiation site, which was tran- 
scribed by the leader RNA with three UCUAA copies 
but not those with two copies, opposite to the tran- 
scription pattern of mRNA 2-l. We, therefore, at- 
tempted to further characterize this site. Figure 1 
shows that mRNA 3-l was synthesized in large quan- 
tity in cells infected with Bl(3) but not with Bl(2) vi- 
ruses, which contained three and two copies of 
UCUAA, respectively. However, neither JHM(2) nor 
JHM(3) synthesized this mRNA, even though the latter 
contained three copies of UCUAA. Thus, other se- 
quences, probably transcription initiation sequence, 
also accounted for the presence or absence of mRNA 
3-1 transcription. In contrast, mRNA 2-l was synthe- 
sized only by JHM(2) but not by Bl(2) viruses, although 
both had two UCUAA copies. This was consistent with 
our previous conclusions (7, IO), since Bl(2) virus had 
an A59-derived gene 2-1 sequence (12), which had a 
defective transcription initiation sequence for this gene 
(7, 11). Similar to the previous observation (7) JHM(2) 
synthesized a smaller amount of mRNA 2 than JHM(3). 
However, the relative amount of this mRNA was vari- 
able from virus preparation to preparation. An addi- 
tional minor RNA species, l-1 , was noted in B1(3)- and 
JHM(3)- but not in B1(2)- or JHM(2)-infected cells, sug- 
gesting that it was also a differentially regulated tran- 
scription initiation site, which was transcribed by the 
leader RNA with three UCUAA copies, but not with two 
copies. Several of these viruses also had additional 
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FIG. 2. Primer extension analysis of the 5’.end of mRNA 3-1 from 
Bl(3). The synthetic oligonucleotide 348 was Y-end-labeled with [y- 
32P]ATP by polynucleotide kinase and extended with reverse tran- 
scriptase as previously described (9). Briefly, poly(A)+ RNA from 
Bl(3))infected DBT cells was denatured with 10 mM methylmercury 
and incubated at 45” for 30 min in 50 ~1 reaction buffercontaining 60 
U of RNasin (Promega Biotech), 10 mM MgCI,, 100 mM KCI, 50 mM 
Tris-hydrochloride, pH 8.3, 10 mM dithiothreitol, 12.5 mM each of 
dATP, dCTP, dGTP, TTP, and 35 U avian myeloblastosis virus re- 
verse transcriptase (Seikagaku). Reaction products were analyzed 
by electrophoresis on a 6% polyacrylamide gel containing 8.3 M 
urea. A sequencing ladder was used as size markers. The primer 
extended product is indicated by an arrow. 
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TABLE 1 
SEQUENCES OF TRANSCRIPTION I ITIATION SITES OF VARIOUS mRNAs 
Copy number 
of UCUAA in mRNA 
mRNA Virus the leader lntergenic site synthesis 
(A) 3-l Bl (3) 3 UCUAAUCUAUC +++ 
B1 (2) 2 UCUAAUCUAUC 2 
A59 2 UCUAAUCUAUC f 
A5ga 2 UCUGCUCUAUC N.D.b 
JHM (2) 2 UCUGCUCUAUC - 
(B) 2-2 JHM (3) 3 UCCGGGUCUUGA - 
MHV-1 3 UUUAA-UCUUGA +++ 
2 UUUAWJCUUGA f 
Note. The genomic sequence at the intergenic site for mRNA 3-l 
was obtained by direct sequencing of cDNA spanning this region, 
which had been amplified by PCR using oligomers 197 and 198 as 
specific primers. cDNA synthesis and PCR amplification were 
carried out as previously described (6). Oligomer 198 (5’.G-A- 
CAAGCTTGACCACCGGTGCAATTA-3’) was complementary to nu- 
cleotides 2676-2695 of gene 3, and oligomer 197 (B-GACTCGAA 
TTCAGTrGATAAGmGCTGTACCCCG-3’) was identical to nucleo- 
tides 1166-l 191 of the same gene (14). The MHV-specific cDNA 
products representing nucleotides 1166-2695 of gene 3 were ex- 
cised from low melting agarose (SeaPlaque, FMC Bioproducts), ex- 
tracted with phenol/chloroform, and sequenced by dideoxyribonu- 
cleotide chain-termination method (16). Sequence determination for 
the transcription initiation site of mRNA 2-2 was described previ- 
ously (6). Underscored letters indicate diverged sequences. 
a Sequence obtained from Luytjes et al. (14). 
b Not determined. 
minor RNA species between mRNAs 3 and 4. As dis- 
cussed previously (6), these RNAs most likely repre- 
sented ribosomal RNAs, which could be removed by 
purification on an oligo(dT) column. 
These results suggested further that mRNA tran- 
scription depends not only on the leader sequence but 
also on the transcription initiation sequence. There- 
fore, we determined the sequences of the transcription 
initiation sites for these optional RNAs. From the 
nested-set structure of MHV mRNAs and on the basis 
of the migration pattern of the RNAs, the transcrip- 
tional start site of mRNA 3-l was predicted to be lo- 
cated within gene 3 of Bl(3) virus at a site approxi- 
mately 2 kb downstream from the initiation site of 
mRNA 3. To determine its exact location, we per- 
formed primer extension studies on poly(A)+ RNA from 
B1(3)-infected DBT cells. A synthetic oligonucleotide 
(oligo 348, 5’-ATTAGGAAGCGCCTCATCCG-3!) com- 
plementary to nucleotides 2072-2092 of the published 
A59 gene 3 sequence (14) was used as a primer. The 
5’-end-labeled primer was hybridized to poly(A)+ RNA 
and extended with reverse transcriptase. Primer exten- 
sion products were then analyzed by electrophoresis 
on a 6%~ polyacrylamide gel containing 8 M urea (10). 
As shown in Fig. 2, an extension product of 204 nu- 
cleotides was detected. Since the leader sequence of 
Bl(3) was approximately 75 nucleotides long (8, 9), this 
result suggested that the transcription initiation site of 
mRNA 3-l was located around nucleotide 1955 of 
gene 3. This conclusion was also supported by the 
primer extension reaction using a different primer, 
oligo 42 (5’-GATACCCAGTAGllXTG-3’), which was 
complementary to nucleotides 2151-2171 of gene 3 
and was located 80 bases downstream of the oligo 
348 binding site. The extension product was 284 nu- 
cleotides long (data not shown), consistent with the 
transcription initiation site determined using oligo 348 
as a primer. 
To precisely define the transcription initiation site of 
mRNA 3-1, the 5’-unique portion of mRNA 3-l was 
cloned after amplification by polymerase chain reac- 
tion (PCR). For this purpose, intracellular RNA from 
B1(3)-infected cells was reverse transcribed using 
oligo 42 as a primer and then amplified with oligo 78 
(5’-AGCTTTACGTACCCTCTCTACTCTAAAACTCTT- 
TGTACTTT-3’) as a second primer. The latter primer 
was homologous to the middle portion of the leader 
RNA and contained seven additional nucleotides repre- 
senting the SnaBl site (15). The 280-nucleotide-long 
PCR product thus represented the 5’-end (including the 
leader sequence) of mRNA 3-l and was cloned into the 
Smal site of the pTZ18U vector (U.S. Biochemicals) by 
blunt-end ligation as previously described (6). Nucleo- 
tide sequence analysis of cDNA clones showed that 
the sequence of mRNA 3-l diverged from that of the 
genomic RNA immediately upstream of the sequence 
UCUAAUCUAUC, which was located at nucleotides 
1950-l 961 of gene 3 (14), indicating that this region 
was the transcription initiation site of mRNA 3-l (data 
not shown) (Table 1). Significantly, the copy number of 
UCUAA sequence in the leader region of different 
cDNA clones varied from two to four (data not shown). 
This observation was in agreement with the previously 
described heterogeneity of MHV mRNA, possibly re- 
sulting from the imprecise interaction between the 
UCUAA sequence at the 3’-end of the leader RNA and 
the transcription initiation sequence (9). This finding 
further established that this sequence represented a 
bona fide transcription initiation site of MHV mRNA. 
However, the sequence determined here was differ- 
ent from the corresponding sequence of the published 
A59 gene 3 (14) (Table l), even though Bl(3) virus de- 
rived its gene 3 from the parental A59 virus (12). This 
result suggested that the parental A59 virus used in 
our laboratory may have a different sequence in this 
region. We therefore used the same procedures to se- 
quence the A59 used in our laboratory. The results 
showed that its sequence was identical to that of Bl(3) 
A 
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FIG. 3. Alteration of mRNA synthesis and leader RNA sequence of MHV-1 during serial passage in DBT cells. (A) MHV-1 was plaque-purified 
twice and propagated twice on DBT cells to generate a high-titer virus stock (designated Pl). Subsequently, 0.2 ml of the virus stock was added 
onto a fresh 6-cm plate of DBT cells, and the supernatant (designated P2) from this culture was collected after 24 hr. Thirteen subsequent 
passages were performed by the same procedure (designated P2-H to P15-H). DBT cells infected with supernatants P5-H, P8-H, Pl O-H, and 
P15-H were used for 32P-labeling of intracellular viral RNA. To eliminate defective-interfering (DI) RNA, virus stocks from each passage were 
diluted 1 04-to 1 OS-fold and used to infect DBT cells at a multiplicity of infection (m.0.i.) of 0.000 1. The supernatant was harvested 24 to 36 hr p.i. 
Some of the supernatants from low m.o.i. infection (P5-L, PlO-L, and P15-L) were used to infect fresh DBT cells and labeled with [3ZP]- 
orthophosphate. RNAs were analyzed by electrophoresis as described in Fig. 1. mRNA 2-l and 2-2 are indicated by asterisks. The DI RNAs are 
indicated by arrows. (B) The virion RNA of P5-H, Pl O-H, or P15-H virus was used for primer extension studies using a primer complementary to 
nucleotides 172-l 88 from the 5’.end of JHM genomic RNA according to the procedures as described in Fig. 2. As demonstrated previously (9). 
the extended product was 188 nucleotides long if the leader RNA contained three UCUAA copies (indicated by an arrow) and 183 nucleotides 
long if it contained two copies (indicated by an arrowhead). A DNA sequencing ladder was run In parallel to serve as size markers. 
virus in this region, confirming that this was the authen- 
tic sequence of the parental and recombinant viruses 
(Table 1). This result also explained why mRNA 3-1 
was not synthesized by JHM(3), inasmuch as the se- 
quence of JHM in this region was the same as that of 
the published A59, which did not make mRNA 3-l (Ta- 
ble 1). Additionally, we sequenced Bl(2) virus, which 
failed to make mRNA 3-1, and found that its sequence 
was identical to that of Bl(3) and the parental A59 
within this region. The sequence identity between 
Bl(2) and Bl(3) extended for at least 100 nucleotides 
on either side of the transcription initiation site for 
mRNA 3-1. Therefore, we concluded that the differ- 
ence in mRNA 3-l synthesis by B1(2), B1(3), and A59 
was most likely due to the difference in the copy num- 
ber of the UCUAA pentanucleotide in the leader RNA. 
We have recently identified another novel mRNA 
species (mRNA 2-2) in cells infected with another strain 
of MHV, MHV-1 (6). The transcription initiation se- 
quence of this mRNA was similar to but slightly differ- 
ent from the consensus sequence for MHV mRNAs 
(Table 1). To determine whether this novel RNA was 
differentially regulated by the copy number of UCUAA 
in the leader RNA, we performed undiluted serial pas- 
sages of MHV-1 in DBT cells. The 32P-labeled intracel- 
lular viral RNA isolated from virus-infected cells at dif- 
ferent passage levels were examined by electrophore- 
sis on agarose gel. To rule out the effects of 
defective-interfering (DI) RNA, we have also examined 
intracellular viral RNAs after a low multiplicity of infec- 
tion (m.o.i.) passage of the different virus isolates to 
remove DI RNAs. Figure 3A shows that the original 
MHV-1 synthesized mRNA 2-2 in addition to the seven 
standard mRNAs. After 10 passages in DBT cells, the 
virus did not synthesize mRNA 2-2, but instead synthe- 
sized mRNA 2-1, which had previously been character- 
ized as being transcribed by the leader RNA with two 
UCUAA copies (7). At both passages 5 and 8, both of 
these mRNAs were synthesized. No difference in the 
intracellular viral RNA pattern could be detected in the 
presence or absence of DI RNA at every passage level. 
To determine whether the change of mRNA 2-1 and 
2-2 expression correlated with the UCUAA copy num- 
ber in the leader RNA, we examined the structure of 
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TABLE 2 
MINOR TFNNSCRIPTION INITIATION SITES WITHIN GENE 1 
41 
Leader 5 ---AAAACTCTTGTAGTTTAAATCTAATCTAATCTAAAC ~- 
Primer 78 1 2 3 
Genome 
mRNA 
Genome 
mRNA 
5780 
TTTAATGTACCATTTTTAATCTGCTCC --- 
I I I I I I I 
TAGTTTAAATCTAATCTAATCT(GCTCC) -- 
1 2 3 
5888 
CATGTGAAATGTAAACCCAA - 
I I I I I I I 
TAGTTTAAATCTAA. (CCCAA)- - - 
1 
Genome 
mRNA 
7923 
AGTTGAAACGCCCTGTGAATCCAACAGA--- 
III1 II 
TAGTTTAAATCTAATCTAATCTAA(CAGA)--- 
1 2 3 
Note. Oligonucleotide primers complementary to different regions of gene 1 (around nucleotides 5942 and 7999, respectively) (2) were used 
separately as primers for reverse transcription of the intracellular RNA from JHM(3)infected cells. A second primer (78) representing leader RNA 
sequence (nucleotides 22 to 56) was then used for PCR amplification by Ta9 polymerase. The PCR products were cloned into pTZ18U vector 
and sequenced. The sequences were aligned with the published gene 1 sequence (2). The regions where the mRNA sequences diverged from 
the published genomic sequences were identified, which represented the transcription initiation sites for these mRNAs. The UCUAA copy 
numbers within the leader RNA of each mRNA are indicated. The nucleotide numbers indicated in the genomic sequences represent nucleotide 
positions from the Y-end of the genome (2). 
the leader RNA of MHV-1 at different passage levels by 
primer extension and sequencing. The results showed 
that both virus isolates from passage levels 10 and 15 
had two UCUAA copies (Fig. 38) in contrast to the 
original MHV-1, which had three UCUAA copies (6). 
Interestingly, the virus at passage level 5 contained a 
mixture of two and three UCUAA copies, correspond- 
ing to the detection of both mRNA 2-l and 2-2 (Fig. 3A). 
This result suggested that the leader sequence of 
MHV-1 underwent evolution from three to two UCUAA 
copies during passage in culture, similar to that of JHM 
virus (IO), and that the synthesis of mRNAs 2-2 and 2-l 
correlated well with the presence of three and two 
UCUAA copies in the leader, respectively. The entire 
MHV-1 leader sequence was identical to that of JHM 
(data not shown). This result indicated that the initia- 
tion site of mRNA 2-2 of MHV-1 was utilized by the 
leader sequence with three but not two UCUAA cop- 
ies. Additionally, RNA l-l was also found to be tran- 
scribed only by MHV-1 with three UCUAA copies, but 
not by those with two copies (Fig. 3A), consistent with 
the findings with JHM and Bl viruses (Fig. 1). 
We attempted to determine the transcription initia- 
tion site of RNA l-l by PCR cloning. Using various 
primers representing sequences of different regions of 
gene 1 of the JHM strain of MHV (2) and a second 
primer representing the 5’-end of the leader RNA, we 
detected several PCR products which represented 
mRNAs initiated from various sites. These transcription 
initiation sequences appeared to bear some resem- 
blance to the consensus transcription initiation signal 
(Table 2). We have also attempted to perform primer 
extension studies to determine which of these was the 
transcription initiation signal for RNA l-l. However, 
since the transcription initiation site of RNA l-l was 
located within a gene of 22 kb (2) and the molar amount 
of this RNA was much less abundant than the other 
mRNAs, the results were not conclusive. Neverthe- 
less, the detection of these PCR products with the 
correct leader sequence indicated that these se- 
quences, which were similar to the consensus inter- 
genie sequence, could be utilized as transcription initia- 
tion sites, although at a very low efficiency. 
To determine whether these optional and differen- 
tially regulated RNAs encode any truncated products 
of the viral proteins, we examined the virus-specific 
protein synthesis in the cells infected with Bl(3) and 
other viruses by labeling with [35S]methionine and pre- 
cipitating with antiserum specific for MHV. No proteins 
other than the S, N, M and, in some cases, HE, were 
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detected (data not shown). Thus, mRNAs 2-2 and 3-l 
are most likely not functional. However, other possibili- 
ties, such as rapid turnover of the protein or the ineffi- 
ciency of immunoprecipitation because of the change 
of epitopes on the protein, cannot be ruled out. Since 
the gene product of mRNA 1 is a nonstructural protein 
and has not been identified, we cannot determine 
whether mRNA l-l, which represents a truncated ver- 
sion of mRNA 1, is functional. 
These studies have identified, thus far, at least four 
transcription initiation sites which were regulated in a 
different manner by the leader RNA with different copy 
numbers of UCUAA sequence. Several of these 
(mRNAs 2-2, 3-1, and l-1) were transcribed efficiently 
by the leader sequence with three UCUAA copies, 
while the other (mRNA 2-l) was transcribed efficiently 
by those with two copies. It is not clear how the inter- 
action of these intergenic sequences with the leader 
RNA containing different copy numbers of UCUAA can 
affect transcription initiation. It is possible that this in- 
teraction requires RNA-protein interactions involving 
RNA polymerase and transcription factors, but not sim- 
ply base-pairing between the leader RNA and the inter- 
genie sequences. The three-dimensional structure of 
RNA may be affected by the copy number of UCUAA. 
Since these intergenic sequences are identical in the 
same pair of viruses studied here, these results 
strongly suggest that the leader RNA plays a regulatory 
role for transcription. This interpretation is most con- 
sistent with the leader-primed transcription mecha- 
nism (1) proposed for MHV mRNA synthesis. 
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